Events
Retrophin, Inc. announced that Eric Dube, Ph.D., chief executive officer, will present at the following upcoming investor conferences in March
TESARO Announces Data Presentations at the 2019 SGO Annual Meeting on Women’s Cancer
Esperion, the Lipid Management Company focused on developing and commercializing complementary, cost-effective, convenient, once-daily, oral therapies for the treatment of patients with elevated low density lipoprotein cholesterol, today announced that the company will participate in analyst-led fireside chats with investors at the following conferences
Bristol-Myers Squibb and Celgene Corporation are strongly urging shareholders to submit their proxy votes as quickly as possible whether they plan to attend the April 12, 2019 Special Meeting or not. The meeting is when the official vote on whether Bristol-Myers Squibb will buy Celgene will take place.
MorphoSys AG will publish its Annual Financial Results 2018 on March 13, 2019 at 10:00pm CET.
Esperion announced that the results from Study 2 of bempedoic acid will be presented in a late-breaking clinical trial session at the American College of Cardiology Scientific Sessions & Expo in New Orleans on Monday, March 18th 2019.
Medtronic plc, the global leader in medical technology, announced it will participate in the Barclays Global Healthcare Conference 2019 on Tuesday, March 12, 2019, in Miami, Florida.
Medtronic plc, the global leader in medical technology, announced it will participate in the 39th Annual Cowen and Company Healthcare Conference on Monday, March 11, 2019, in Boston, Massachusetts.
NOXXON Pharma N.V. announced that the company will present the latest safety, survival and more mature clinical data in patients treated with the CXCL12 inhibitor NOX-A12 in combination with Merck & Co./MSD’s PD-1 inhibitor Keytruda® in metastatic, microsatellite stable pancreatic and colorectal cancer patients.
PRESS RELEASES